McCarthy Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
McCarthy Asset Management's GILD Position: Q3 2024 in Review
McCarthy Asset Management sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 130,363 shares — an estimated $8.94M sold.
McCarthy Asset Management first reported a position in GILD in Q4 2020 and held it in 15 quarters. The position peaked at $11.4M in Q4 2022. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.
- McCarthy Asset Management reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
- McCarthy Asset Management sold 130,363 Gilead Sciences shares in Q3 2024, an estimated $8.94M.
- McCarthy Asset Management first reported a position in Gilead Sciences in Q4 2020 and held it in 15 quarters.
- McCarthy Asset Management's Gilead Sciences position peaked at $11.4M in Q4 2022.
- 1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.
Based on McCarthy Asset Management's 13F filing for Q3 2024, filed 18 Nov 2024.